Zobrazeno 1 - 2
of 2
pro vyhledávání: '"GUSTA trial study group"'
Autor:
Barbara Rossetti, Roberta Gagliardini, Genny Meini, Gaetana Sterrantino, Vincenzo Colangeli, Maria Carla Re, Alessandra Latini, Manuela Colafigli, Francesca Vignale, Stefano Rusconi, Valeria Micheli, Antonio Di Biagio, Giancarlo Orofino, Valeria Ghisetti, Alessandra Fantauzzi, Vincenzo Vullo, Pierfrancesco Grima, Daniela Francisci, Claudio Mastroianni, Andrea Antinori, Michele Trezzi, Lucia Lisi, Pierluigi Navarra, Benedetta Canovari, Antonella D'Arminio Monforte, Silvia Lamonica, Alessandro D'Avino, Maurizio Zazzi, Simona Di Giambenedetto, Andrea De Luca, for GUSTA trial study group
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187393 (2017)
Primary study outcome was absence of treatment failure (virological failure, VF, or treatment interruption) per protocol at week 48.Patients on 3-drug ART with stable HIV-1 RNA
Externí odkaz:
https://doaj.org/article/01504d6118df485ca70498de68f4a167
Autor:
Rossetti, B., Gagliardini, R., Sterrantino, G., Colangeli, V., Latini, A., Colafigli, M., Vignale, F., Rusconi, S., Di Biagio, A., Orofino, G., Mezzaroma, I., Vullo, V., Francisci, D., Mastroianni, C., Trezzi, M., Canovari, B., Lamonica, S., Ciccullo, A., Borghetti, A., D'Arminio Monforte, A., Di Giambenedetto, S., De Luca, A., GUSTA trial study group
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes (1999)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960be3bf4667a843383a4514dd83c591
https://hdl.handle.net/11567/992013
https://hdl.handle.net/11567/992013